Ontario Minister of Energy and Electrification Stephen Lecce announced plans for a new hot cell facility to process medical radioisotopes during a visit to the plant which will enter its Major Component Replacement outage on 1 February. Meanwhile, Ontario's Green Party has passed a resolution reversing its blanket opposition to nuclear energy.

Bruce Power has set out its plans to expand production of medical radioisotopes in its Candu reactors. As well as increasing long-term lutetium-177 production capacity, the company also wants to explore the production of other isotopes using its proprietary system.

China has set a target for its nuclear technology application industry to generate annual direct economic output value of CNY400 billion (USD55.7 billion) by 2026.

The 24 months since commercial production of the medical isotope began at the Candu unit have seen Bruce Power and its partners expand production capabilities to match growing global demand.

A 50% increase in molybdenum-99 and 22% more iodine-131 will be produced by adding an extra shift and increasing the hours of irradiation at the RA-3 reactor, Argentina's National Atomic Energy Commission (CNEA) has said.

Romania's nuclear power plant operator Nuclearelectrica and France's Framatome are aiming to launch a full-scale commercial irradiation service for medical isotopes in 2028.

TerraPower Isotopes announced it is producing actinium-225 at commercial scale. The medical radioisotope is being produced from material recovered from a legacy uranium-233 inventory at a US national laboratory.

Kronos Advanced Technologies Inc and Yasheng Group have announced a strategic collaboration to develop and file a patent for a small nuclear battery powered by the decay of nickel-63. The partnership aims to address critical energy storage needs across various sectors, including remote sensing, space exploration, medical devices and military applications.

Canadian Nuclear Laboratories has received shipments of disused radium-226 sources from the Thailand Institute of Nuclear Technology, which will be recycled to produce actinium-225 to be used in targeted radiotherapy.